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Abstract: Feline calicivirus (FCV) is a pathogen of felids and one of the most common causative agents 
of feline upper respiratory disease (URD). Reports of natural FCV pneumonia in the course of 
respiratory tract infections are sparse. Therefore, knowledge on the pathogenesis of FCV-induced lung 
lesions comes only from experimental studies. The aim of the present study was to assess the type and 
extent of pulmonary involvement in natural respiratory FCV infections of domestic cats and to identify 
the viral target cells in the lung. For this purpose, histology, immunohistochemistry and RNA-in situ 
hybridisation for FCV and relevant cell markers were employed in diagnostic post-mortem specimens 
collected after fatal URD, virulent systemic FCV or other conditions. All groups of cats exhibited similar 
acute pathological changes, dominated by multifocal desquamation of activated alveolar macrophages 
(AM) and occasional type II pneumocytes with fibrin exudation, consistent with diffuse alveolar 
damage (DAD). In fatal cases, this was generally seen without evidence of epithelial regeneration. In 
cats without clinical respiratory signs, type II pneumocyte hyperplasia was present alongside the other 
changes, consistent with the post-damage proliferative phase of DAD. FCV infected and replicate in AM 
and, to a lesser extent, type II pneumocytes. This study shows that lung involvement is an infrequent 
but important feature of FCV-induced URD. AM are the main viral target cell and pulmonary replication 
site, and their infection is associated with desquamation and activation, as well as death via apoptosis. 
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 Abstract 26 
Feline calicivirus (FCV) is a pathogen of felids and one of the most common causative 27 
agents of feline upper respiratory disease (URD). Reports of natural FCV pneumonia in the 28 
course of respiratory tract infections are sparse. Therefore, knowledge on the pathogenesis of 29 
FCV-induced lung lesions comes only from experimental studies. The aim of the present 30 
study was to assess the type and extent of pulmonary involvement in natural respiratory FCV 31 
infections of domestic cats and to identify the viral target cells in the lung. For this purpose, 32 
histology, immunohistochemistry and RNA-in situ hybridisation for FCV and relevant cell 33 
markers were employed in diagnostic post-mortem specimens collected after fatal URD, 34 
virulent systemic FCV or other conditions. All groups of cats exhibited similar acute 35 
pathological changes, dominated by multifocal desquamation of activated alveolar 36 
macrophages (AM) and occasional type II pneumocytes with fibrin exudation, consistent with 37 
diffuse alveolar damage (DAD). In fatal cases, this was generally seen without evidence of 38 
epithelial regeneration. In cats without clinical respiratory signs, type II pneumocyte 39 
hyperplasia was present alongside the other changes, consistent with the post-damage 40 
proliferative phase of DAD. FCV infected and replicate in AM and, to a lesser extent, type II 41 
pneumocytes. This study shows that lung involvement is an infrequent but important feature 42 
of FCV-induced URD. AM are the main viral target cell and pulmonary replication site, and 43 
their infection is associated with desquamation and activation, as well as death via apoptosis. 44 
 45 
Keywords: Feline calicivirus; Pulmonary infection; Alveolar macrophages; 46 
Immunohistochemistry; RNA-in situ hybridisation 47 
48 
 Introduction 49 
Feline calicivirus (FCV) is one of the most common causative infectious agents of 50 
feline upper respiratory disease (URD; Bannasch and Foley, 2005; Di Martino et al., 2007; 51 
Gaskell et al., 2012). URD is widespread and common in cats and presents with a variety of 52 
clinical signs, including conjunctivitis, rhinitis, oral ulcers and, occasionally, pneumonia 53 
(Hurley and Sykes, 2003; Gaskell et al., 2006; Radford et al., 2007; Pesavento et al., 2008; 54 
Radford et al., 2009). The mortality rate is usually low, but occasionally kittens develop fatal 55 
pneumonia (Love and Baker, 1972; Turnquist and Ostlund, 1997). 56 
 57 
FCV is a member of the Caliciviridae, which possess a non-enveloped, positive-sense, 58 
single-stranded RNA genome of approximately 7.5 kb (Clarke and Lambden, 1997). The 59 
virus exhibits high genetic variability and there are a variety of natural strains (Radford et al., 60 
2003) with variable cell tropism, pathogenesis and virulence, resulting in different clinical 61 
manifestations, such as self limiting URD, lameness due to acute synovitis (Dawson et al., 62 
1994) and systemic disease caused by highly virulent strains, so-called virulent systemic 63 
(VS)-FCV (Hurley and Sykes, 2003; Radford et al., 2007; Pesavento et al., 2008). The genetic 64 
diversity of FCV is a consequence of changes in the hypervariable C and E regions that 65 
encode part of the capsid proteins involved in the generation of neutralising antibodies 66 
(Radford et al., 1999; Geissler et al., 2002). Animals develop a protective immune response 67 
against FCV (Kahn et al., 1975; Kahn and Hoover, 1976; Scott, 1977); however, continual 68 
genomic changes in the virus can lead to reinfections with different strains or closely related 69 
variants of the same strain, despite previous infection episodes (Johnson, 1992; Radford et al., 70 
2003; Coyne et al., 2006b, 2007). Due to the genetic instability of FCV, effective disease 71 
prophylaxis has remained challenging (Radford et al., 1997) and, after years of vaccination 72 
programmes, infection is still widespread, leading to the search for new heterologous vaccines 73 
 that can protect against more than one strain (Poulet et al., 2005; Radford et al., 2006). 74 
Moreover, in 1998, new highly virulent VS-FCV strains emerged. The first VS-FCV cases 75 
were observed in California (Pedersen et al., 2000), but further outbreaks have subsequently 76 
been reported from the USA (Schorr-Evans et al., 2003; Hurley et al., 2004; Pesavento et al., 77 
2004) and, more recently, Europe (Coyne et al., 2006a; Schulz et al., 2011; Battilani et al., 78 
2013; Velasco et al., 2013). The most frequent clinical signs are cutaneous oedema (mainly on 79 
the head and limbs), ulceration of the skin and mucosa, predominantly affecting the oral 80 
cavity, nares, pinnae and footpads, and clinical signs due to multi-organ necrosis, most 81 
commonly affecting the liver, but occasionally also the spleen, pancreas or lungs (Pedersen et 82 
al., 2000; Hurley and Sykes, 2003; Coyne et al., 2006a; Radford et al., 2007; Pesavento et al., 83 
2008; Radford et al., 2009). 84 
 85 
Reports of natural FCV pneumonia are sparse and our understanding of the 86 
pathogenesis of FCV-induced lung lesions is from experimental studies only. These used high 87 
doses (up to 2 x 10
4
 median tissue culture infective dose) of virus propagated in tissue culture 88 
in an aerosol for the intranasal infection of kittens and young cats, which often resulted in 89 
pulmonary involvement (Holzinger and Kahn, 1970; Kahn and Gillespie, 1971; Hoover and 90 
Kahn, 1973, 1975; Love, 1975; Langloss et al., 1978a). The development and type of lung 91 
lesions was generally similar; after an initial phase of pneumocyte injury with exudation and 92 
neutrophil infiltration, proliferation of type II pneumocytes and desquamation of alveolar 93 
macrophages (AM) into the alveolar lumen was observed. Virus was detected by 94 
immunofluorescence in pneumocytes and AM (Holzinger and Kahn, 1970; Kahn and 95 
Gillespie, 1971). Some authors suggested a correlation between the type of virus inoculum 96 
and the clinical signs (Love, 1975; Ormerod et al., 1979), and it has since been accepted that 97 
the experimental studies overemphasise the relevance of FCV-associated pneumonia, since 98 
 natural infection mainly occurs via the oronasal route (Radford et al., 2007; Gaskell et al., 99 
2012). However, other authors have suggested that severe pneumonia might not be rare in 100 
naturally infected cats (Pesavento et al., 2008). 101 
 102 
Definitive reports of pneumonia as a complication of severe, naturally acquired FCV-103 
associated respiratory disease are very rare (Love and Baker, 1972; Turnquist and Ostlund, 104 
1997). Furthermore, attempts to demonstrate the virus in the lungs to assess whether FCV or 105 
bacteria, such as Bordetella bronchiseptica, were the relevant pulmonary pathogen, have not 106 
been made (Turnquist and Ostlund, 1997). This study, which was initiated after acute 107 
pneumonia and FCV infection had been diagnosed post-mortem in a number of cats with 108 
URD, aimed to assess the type and extent of pulmonary involvement in natural respiratory 109 
FCV infections of domestic cats, and to identify the viral target cells in the lung. For this 110 
purpose, histopathology, immunohistochemistry (IH) and RNA-in situ hybridisation were 111 
employed on post-mortem specimens from cats with fatal URD, VS-FCV or other conditions. 112 
 113 
Materials and methods 114 
Animals and tissues 115 
The study was performed on specimens from cats from Germany, the UK, Finland, Italy 116 
and Spain that had undergone full diagnostic post-mortem examinations. Tissue specimens 117 
had been collected for histological examination and, in some cases, for virological and 118 
bacteriological examinations (Tables 1-4). Four groups were included. Group 1 comprised 119 
eight cats with clinical histories of URD and pneumonia. FCV was isolated from the lungs by 120 
virus culture and involvement of FCV in the pneumonia was confirmed by IH. Group 2 121 
comprised five cats with URD and pneumonia. Virus culture was not performed, but FCV 122 
involvement was confirmed by IH. Group 3 comprised two cats without URD. These had 123 
been euthanased because of feline parvovirus infection, but exhibited histopathological 124 
 findings consistent with FCV pneumonia, confirmed by FCV IH. Group 4 comprised four cats 125 
with VS-FCV; pulmonary specimens from these cats were examined by IH for the presence 126 
and distribution of FCV. Most of the cats in group 4 have since been reported as confirmed 127 
cases of VS-FCV in the UK (Coyne et al., 2006a), Italy (Battilani et al., 2013) and Spain 128 
(Velasco et al., 2013). 129 
 130 
All lung tissue specimens were fixed in 10% non-buffered formalin for 24-72 h, 131 
followed by trimming and routine paraffin wax embedding. Specimens of tongue, larynx or 132 
nose were also examined when they showed gross lesions associated with URD. Other 133 
tissues/organs (spleen, liver, kidney, intestine, brain) were processed for histological 134 
examination, to identify or exclude any concurrent disease. 135 
 136 
Histology 137 
Sections (3-5 µm thick) were prepared and stained with haematoxylin and eosin for 138 
histopathological examination. Consecutive sections were prepared and mounted on polysine 139 
slides (VWR International Eurolab S.L) for IH and RNA-in situ hybridisation. 140 
 141 
Immunohistochemistry 142 
IH was used to demonstrate viral antigen (FCV and, in most specimens from groups 1 and 143 
2, FHV, to exclude FHV infection of the lung and to confirm the involvement of FHV in one 144 
case of ulcerative glossitis,), type II pneumocytes (surfactant protein, SP-C, positive), AM 145 
(CD18 positive), apoptotic cells (cleaved caspase-3 positive) and the functional marker matrix 146 
metalloproteinase (MMP)-9 in the lungs. FCV antigen expression was also assessed in other 147 
lesions consistent with URD to confirm aetiology and in other organ specimens from cats 148 
with VS-FCV (Coyne et al., 2006a; Battilani et al., 2013). 149 
  150 
The peroxidase anti-peroxidase (PAP), avidin biotin complex peroxidase (ABC) and 151 
horseradish peroxidase (HRP) methods were applied, as previously described (Kipar et al., 152 
2005; Coyne et al., 2006a; Leeming et al., 2006). All antibodies, antigen retrieval and 153 
detection methods are listed in Table 5. The two antibodies against FCV were both used on 154 
consecutive sections of the same case (cats in group 1; with similar staining results), or were 155 
used alternatively. 156 
 157 
A formalin-fixed and paraffin-embedded cell pellet prepared from an FCV infected 158 
tissue culture (see below), and sections prepared from a case of glossitis with strong 159 
expression of FCV antigen, a similarly prepared FHV-infected cell pellet and a specimen 160 
from a cat with necrotising rhinitis with strong FHV antigen expression served as positive 161 
controls for the virus IH; a specimen with granulomatous dermatitis was used as control for 162 
the functional markers. Negative controls were represented by consecutive sections in which 163 
the primary antibody was omitted or replaced by a non-reacting polyclonal antibody against 164 
Toxoplasma gondii or a mouse monoclonal antibody against canine distemper virus. 165 
 166 
RNA-in situ hybridisation 167 
Virus cultivation, RNA extraction and cDNA preparation - The FCV strain F9 (Carter et 168 
al., 1992) was cultured in feline embryo A (FEA) cells using standard protocols (Povey and 169 
Johnson, 1971; Carter et al., 1992) and a multiplicity of infection of 0.001 plaque forming 170 
units/cell in a volume of 5 mL growth medium. RNA was extracted and reverse transcribed 171 
into cDNA, as previously described (Coyne et al., 2007). 172 
 173 
 Preparation of riboprobes - Nine full genome FCV nucleotide sequences were retrieved 174 
from GenBank
1
 (accession numbers AY560115, AY560113, M86379, D31836, AF479590, 175 
L40021, AF109465, DQ424892 and AY560117) and aligned using CLUSTAL W alignment 176 
editor MEGA version 4 (Tamura et al., 2007). A pair of primers, forward and reverse, were 177 
designed to amplify a relatively conserved region of ORF1 from residues 2420 to 2550 of the 178 
FCV genome (FCV 2420-fw: 5’-GAACTACCCGCCAATCAACATGTGGTAAC-3’ and 179 
FCV 2550-rev: 3’-GGGACAGTTAGCACRTCRTATGCGGC-5’), to produce an amplicon of 180 
130 base pairs (A.D. Radford, personal communication). The PCR product amplified from the 181 
viral cDNA was cloned into a plasmid vector (pCRII, Invitrogen, Life Technologies), using a 182 
commercially available kit (TOPO TA cloning kit, Invitrogen), and a digoxigenin (DIG)-183 
labelled probe was generated by in vitro transcription, as previously described (Hughes et al., 184 
2011), using a DIG RNA labelling kit (Roche Diagnostics) to generate sense and anti-sense 185 
riboprobes. The correct concentration of the probe for use on tissue sections was determined 186 
empirically using dot blots and RNA-ISH on formalin-fixed, paraffin-embedded pelleted cells 187 
from FCV-infected cell cultures. 188 
 189 
RNA-in situ hybridisation - RNA-ISH was performed according to a previously 190 
published protocol (Kipar et al., 2005). After deparaffinisation, sections were digested with 191 
proteinase K (1 µg/mL, Roche Diagnostics) for 25 min to expose the target RNA, followed by 192 
post-fixation, acetylation and prehybridisation steps. Hybridisation was performed by 193 
incubation of slides at 37 ºC for 15-18 h; the hybridisation mix contained either the anti-sense 194 
probe (for the detection of positive strand viral RNA) or the sense probe (for the detection of 195 
negative strand, replicative intermediate stage viral RNA), respectively. After post-196 
hybridisation washing, probe binding was visualised with alkaline phosphatase-coupled anti-197 
                                                 
1
 See: https://www.ncbi.nlm.nih.gov/genbank/. 
 DIG antibody (anti-DIG-AP FAb fragments; Roche Diagnostics) and nitroblue tetrazolium 198 
chloride (NBT)/5-bromo-4-chloro-3-indolylphosphate (BCIP; SigmaFast
 
BCIP/NBT; Sigma-199 
Aldrich). Sections were counterstained for 10 s with Papanicolaou’s haematoxylin (Merck 200 
KGaA). Sections that were incubated with the hybridisation mix alone served as negative 201 
controls. 202 
 203 
Results 204 
Histopathology associated with feline calicivirus infection of the lungs 205 
Pulmonary specimens from cats with URD and histological evidence of pneumonia, 206 
from which FCV was isolated in culture (group 1), served to identify the type of pathological 207 
changes induced in the lungs after natural FCV infection. Subsequent examination of the 208 
lungs of all other groups (group 2: URD with pneumonia, confirmed by FCV IH alone; group 209 
3: no URD, but pulmonary changes similar to groups 1 and 2; group 4: VS-FCV) confirmed a 210 
range of key histopathological features that were consistently observed in all cats. 211 
 212 
The main finding was multifocal desquamation of large, round, often vacuolated 213 
mononuclear cells into the alveolar lumen, generally in association with fibrin exudation (Fig. 214 
1). The extent of this feature varied, both with regard to the number and distribution of 215 
affected alveoli and the number of desquamated cells in individual alveoli. The desquamated 216 
cells were mostly AM, confirmed by their consistent, strong CD18 expression (Fig. 2A). 217 
Among these were occasional type II pneumocytes, which were identified by their expression 218 
of SP-C (Fig. 2B). The morphology of type II pneumocytes (large, cuboidal cells) often 219 
suggested an activated state, which was also confirmed by IH, since both these cells and AM 220 
expressed MMP-9 (Fig. 2C). A variable proportion of the desquamated cells were undergoing 221 
apoptosis, exemplified by the typical morphology and the expression of cleaved caspase-3 222 
 (Fig. 2D). In areas with extensive alveolar fibrin exudation, fibrin was also found on the 223 
pleura. Occasionally, erythrocyte extravasation into the alveolar lumen was also observed 224 
(Fig. 1B). In rare cases (groups 2 and 3, n = 1 each), mild to focally moderate type II 225 
pneumocyte hyperplasia was observed (Fig. 1C). FCV antigen was expressed by variable 226 
numbers of desquamated AM, which were often apoptotic (Fig. 3). Occasional type II 227 
pneumocytes also expressed viral antigen (Fig. 3B, 3C inset). 228 
 229 
In all eight cats in group 1, pulmonary changes were acute and locally extensive to 230 
diffuse, without evidence of alveolar epithelial cell regeneration or substantial interstitial 231 
leucocyte infiltration. Apart from one case (cat 1.5), all cats had alveolar fibrin exudation 232 
along with desquamation of AM and type II pneumocytes in the lungs (Table 1). When tested, 233 
FCV antigen was also demonstrated in URD lesions, i.e. ulcerative glossitis (cats 1.4 and 2.3) 234 
and rhinitis (cat 2.6). Interestingly, cat 1.5 exhibited FCV and FHV co-infection in the 235 
ulcerative glossitis, but only FCV was detected in the lung by both virus isolation and IH. 236 
 237 
Bacteriology had been performed on all cats in group 1. Pulmonary bacterial infection 238 
with Pasteurella multocida was identified in two cats (cats 1.4 and 1.7); in one case (cat 1.4) 239 
there was a co-infection with γ-haemolytic Streptococcus sp. Septicaemia was diagnosed in 240 
six cats, either with a mixed population of bacterial isolates (cats 1.3-1.6) or haemolytic 241 
Escherichia coli (cats 1.1 and 1.8). One cat (cat 1.4) also had feline parvovirus enteritis, 242 
confirmed by IH. 243 
 244 
Group 2 comprised six cats with URD and pulmonary changes that were identical to 245 
those in group 1. In these cases, FCV involvement was confirmed only by IH for FCV 246 
antigen. In most cases, IH for FHV had been performed concurrently to confirm that FHV 247 
 was not involved (Table 2). In group 2, all but one case (cat 2.4) had alveolar fibrin exudation. 248 
In one case (cat 2.5), the presence of mild focal type II pneumocyte hyperplasia and moderate 249 
interstitial macrophage infiltration indicated a slightly longer course of disease. FCV antigen 250 
was also present in URD lesions, i.e. laryngitis (cat 2.2), glossitis (cat 2.3), and rhinitis (cat 251 
2.6). In one case (cat 2.1), an unidentified Mycoplasma sp. was isolated from the lungs. In the 252 
remaining cases, bacteriological examination either was not performed or did not yield any 253 
predominant bacterial isolates. 254 
 255 
Group 3 was represented by two cats that had been euthanased due to feline parvovirus 256 
enteritis, without clinical or gross pathological signs of URD or pneumonia. Both exhibited 257 
histopathological changes in the lung that were similar to those observed in groups 1 and 2, 258 
the only difference being that they were generally only mild and patchy in the group 3 cats. 259 
However, the presence of moderate multifocal type II pneumocyte hyperplasia (Fig. 1C) 260 
indicated a longer course of disease than in most cats from groups 1 and 2 (Table 3). 261 
 262 
In all cats in group 4, VS-FCV was confirmed by the presence of typical necrotising 263 
organ lesions and, with the exception of cat 4.3, the isolation of FCV from oropharyngeal 264 
swabs or organs, PCR and sequencing (Coyne et al., 2006a; Battilani et al., 2013; Velasco et 265 
al., 2013). The lungs were always involved and showed typical multifocal desquamation of 266 
AM and occasional type II pneumocytes (Table 4). One cat (cat 4.3) had marked alveolar 267 
fibrin exudation and intense desquamation of cells into the alveolar lumina. A few 268 
bronchioles had focal loss of the respiratory epithelium and apoptosis of sloughing epithelial 269 
cells (Fig. 1D). These cells expressed FCV antigen, similar to the desquamated cells in the 270 
alveolar lumina (Fig. 3D). 271 
 272 
 Feline calicivirus replication in the lung 273 
Alongside the demonstration of viral antigen by IH, FCV was demonstrated by RNA-ISH 274 
(positive strand viral RNA; binding to anti-sense riboprobe) within desquamated AM (Fig. 275 
4A, B). RNA-ISH using the sense probe yielded a positive signal in a small proportion of 276 
these cells, confirming that the virus was not only taken up by the cells, but replicated in the 277 
infected cells (Fig. 4A). Viral replication was also demonstrated in activated and hyperplastic 278 
type II pneumocytes (Fig. 4B, C). In the VS-FCV case with infection of bronchiolar 279 
respiratory epithelial cells, viral replication was also demonstrated in these cells (Fig. 4D). 280 
 281 
Discussion 282 
This retrospective study aimed to provide insight into the relevance and effect of FCV 283 
in the lungs of naturally infected cats. For this purpose, we initially examined a group of cats 284 
with URD that had been euthanased, underwent post-mortem examination and had 285 
histological evidence of acute pneumonia in which FCV was suggested to play a role, since 286 
the virus was isolated from the lungs. The key histological feature in these lungs was severe 287 
acute diffuse alveolar damage (DAD), represented by extensive multifocal to diffuse 288 
desquamation of AM (CD18 positive) and occasional type II pneumocytes (SP-C positive; 289 
Mulugeta and Beers, 2006) that accumulated in the alveolar lumen, together with variable 290 
amounts of fibrin and occasional erythrocytes. IH demonstrated FCV antigen in the 291 
desquamated cells, providing strong evidence that the virus played a pathogenic role in the 292 
lungs. The apparent lack of alveolar epithelial regeneration and/or inflammatory cell 293 
recruitment suggests that the cats died or were euthanased due to virus-induced acute DAD, as 294 
a fatal complication of severe FCV-induced URD. 295 
 296 
 We also included cats that had presented with URD and identical acute pulmonary 297 
changes in which a virological examination had not been undertaken. Based on the results of 298 
the first group, we considered IH demonstration of FCV in the desquamated cells to be 299 
diagnostic for acute FCV-associated pneumonia. Subsequent application of the histological 300 
criteria identified another two cases of suspected FCV-induced lung lesions, in which the 301 
involvement of FCV was confirmed by IH. Interestingly, both cats also had feline parvovirus 302 
enteritis. Considering that infection with feline parvovirus not only induces enteritis, but also 303 
marked leucopenia and immunosuppression (Truyen et al., 2009), it is possible that the 304 
observed, albeit mild, pneumonia, was a consequence of viral recrudescence from sites of 305 
persistence, such as the tonsils, due to immunosuppression (Dick et al., 1989; Radford et al., 306 
2007; Gaskell et al., 2012). Also, in both cats, there was evidence of a slightly longer time 307 
course of disease, since both exhibited multifocal type II pneumocyte hyperplasia, a feature 308 
generally observed 6-7 days after pneumocyte damage (Myers et al., 1993; Caswell and 309 
Williams, 2007). This has also been observed 7-14 days after experimental infection of cats 310 
with FCV by the aerosol route (Hoover and Kahn, 1973, 1975; Ormerod et al., 1979). 311 
 312 
The desquamated cells found in the alveolar lumen were mainly AM, admixed with a 313 
few type II pneumocytes. These cells, both detached and, less frequently, attached to the 314 
alveolar wall, were activated, as evidenced by their expression of MMP-9, a gelatinase (92 315 
kDa gelatinase B) that digests collagen IV and thereby the basement membrane, and is 316 
assumed to facilitate the inflammatory cell recruitment (Pardo et al., 1999; Kim et al., 2009). 317 
In most cases with more extensive changes (i.e. severe URD and pneumonia), this cellular 318 
reaction was associated with alveolar fibrin exudation, indicating that not only alveolar cells, 319 
but also vascular endothelial cells were injured, leading to increased vascular permeability. 320 
These vascular effects are typical of acute DAD and result from damage to the extracellular 321 
 matrix induced by, among other factors, MMP-9; consequently, DAD can be mediated by AM 322 
alone (Gibbs et al., 1999; Gushima et al., 2001). 323 
 324 
FCV pneumonia shares many histopathological features with the lungs of fatal human 325 
avian influenza cases; both exhibit DAD, with an acute exudative phase and, later, a 326 
proliferative phase (Nakajima et al., 2013), whereby type II pneumocyte hyperplasia is a 327 
consequence of the initial epithelial and endothelial cell damage (Langloss et al., 1978a; 328 
Myers et al., 1993). 329 
 330 
Pulmonary FCV infection was either associated with URD or appeared to be the only 331 
virally induced lesion in the respiratory tract, indicating that FCV reaches the lung by 332 
inhalation of aerosols after natural infection, confirming that the experimental approach of 333 
older studies was appropriate (Holzinger and Kahn, 1970; Kahn and Gillespie, 1971; Hoover 334 
and Kahn, 1973, 1975; Love, 1975; Langloss et al., 1978a; Ormerod et al., 1979). The 335 
pulmonary changes observed in the present study are similar to those described in 336 
experimentally infected cats, apart from the initial neutrophil recruitment in the latter, which 337 
might be due to the high viral dose administered (Holzinger and Kahn, 1970; Kahn and 338 
Gillespie, 1971; Hoover and Kahn, 1973, 1975; Love, 1975; Langloss et al., 1978a). 339 
However, in the lungs of human beings infected with avian influenza, substantial neutrophil 340 
infiltration has been documented (Nakajima et al., 2013). 341 
 342 
The lung lesions in the four VS-FCV cases (group 4) were histopathologically similar to 343 
those in the other three groups. VS-FCV strains are highly virulent and have both a wider 344 
target cell spectrum and more intense cytopathic effect than other FCV isolates (Radford et 345 
al., 2007; Pesavento et al., 2008). In the lungs, this can result in infection and death of 346 
 respiratory epithelial cells, as indicated by the focal FCV infection and apoptotic loss of 347 
bronchial epithelium observed in one cat in the present study. 348 
 349 
In FCV pneumonia, the virus was mainly identified within AM. RNA-ISH to 350 
demonstrate both positive and negative strand viral RNA showed that it is not only 351 
phagocytosed by the AM, as suggested by previous in vitro studies (Langloss et al., 1978b), 352 
but it also replicates in these cells. Similarly, we found that FCV infected both activated and 353 
hyperplastic type II pneumocytes in the acute lesions and also replicated in those cells. 354 
Hyperplastic type II pneumocytes could be a site for viral persistence in the lungs. Feline 355 
junctional adhesion molecule A (fJAM-A), an immunoglobulin-like molecule that is 356 
expressed in a wide range of feline cells, including epithelial and endothelial cells and 357 
leucocytes (Makino et al., 2006; Ossiboff and Parker, 2007; Pesavento et al., 2011), mediates 358 
FCV attachment and entry into cells. The selected cell tropism of most FCV strains, however, 359 
is likely mediated by α2,6-sialic acids, which are also responsible for the macrophage tropism 360 
of murine noroviruses, which are also members of the Caliciviridae (Makino et al., 2006; 361 
Ossiboff and Parker, 2007; Stuart and Brown, 2007). In contrast, VS-FCV might have an 362 
altered receptor usage, which allows it to infect a wider range of cell types. 363 
 364 
Our study provides strong evidence that FCV induces apoptosis in infected 365 
macrophages and respiratory epithelial cells in vivo. This supports in vitro studies, which 366 
demonstrated that FCV infection induces caspase activation, including caspase-3, which we 367 
used to confirm cell death via apoptosis using IH (Sosnovtsev et al., 2003; Natoni et al., 368 
2006). 369 
 370 
 In a few cases, we found co-infection of FCV with FHV-1 or bacteria. FCV and FHV-1 371 
co-infection of the upper respiratory tract is a known feature of URD and was recently found 372 
in 9% of cats that tested positive for either virus in a cat population in Brazil (Henzel et al., 373 
2012). The presence of a concomitant bacterial infection with Pasteurella multocida or 374 
Mycoplasma spp., both opportunistic pathogens that are part of the normal nasopharyngeal 375 
bacterial population (Gaskell et al., 2012), are secondary and are likely be established after 376 
DAD. 377 
 378 
Conclusions 379 
In this study, lung involvement was an infrequent, but relevant, feature of FCV-380 
induced URD. Acute FCV-induced lung lesions were consistent with DAD. AM were the 381 
main viral target cells and the site of viral replication in the lung, and their infection was 382 
associated with desquamation, activation and apoptosis. 383 
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 Table 1 632 
Relevant gross and histological findings for group 1: Cats with upper respiratory disease (URD) and pneumonia, 633 
involvement of feline calicivirus (FCV) confirmed by isolation of FCV from the lungs and 634 
immunohistochemistry (IH) for FCV antigen. 635 
 636 
Case Breed Age Sex Lung histopathology  Demonstration of FCV 
1.1 
 
ESH 11 years F Multifocal mild to moderate fibrin exudation and low numbers of AM/type II 
pneumocytes a in AL 
IH: Scattered cells in AW (type II 
pneumocytes) and in AL (AM) 
1.2 
 
DSH 8 weeks NK Multifocal moderate to marked fibrin exudation and moderate numbers of 
often apoptotic b AM/type II pneumocytes with a few neutrophils in AL; 
bronchiolar lumen with similar content; moderate hyperaemia and 
perivascular oedema  
IH: Moderate numbers of cells in AL, 
occasional cells in AW 
ISH (S, AS): Moderate number of cells in AL 
(IH, FHV: Negative) 
1.3 
 
DSH 12 weeks F Multifocal marked fibrin exudation and abundant AM/ type II pneumocytes 
in AL; bronchiolar lumen with similar content; diffuse fibrin exudation on 
pleura 
IH: Low numbers of cells in AL 
ISH (S, AS): Low number of cells in AL  
1.4 
 
DSH 8 weeks F Multifocal moderate to marked fibrin exudation and abundant, occasionally 
apoptotic AM/type II pneumocytes in AL; moderate numbers of extravasated 
erythrocytes and erythrophagocytosis in AL; bronchioles with similar content 
and with focal loss and degeneration of epithelial cells and presence of 
macrophages 
IH: Low to moderate numbers of cells in AL, 
some macrophages/degenerate epithelial cells 
in bronchiolar wall. 
ISH (S, AS): Low number of cells in AL 
1.5 
 
ESH 6 years MN Multifocally, low to moderate numbers of AM/type II pneumocytes in AL; 
marked alveolar oedema and occasional extravasated erythrocytes in AL 
IH: Low numbers of cells in AL 
(IH, FHV: Positive, tongue; negative, lung) 
1.6 
 
MC 1 week M Multifocal mild to moderate alveolar fibrin exudation and desquamation of 
abundant, often apoptotic AM and type II pneumocytes; bronchioles with 
similar content 
IH: Moderate numbers of desquamated cells 
in alveoli 
ISH (S, AS): Scattered cells in alveolar lumen 
1.7 
 
MC 12 weeks F Multifocal moderate fibrin exudation and abundant, often apoptotic AM and 
type II pneumocytes in AL, in focal area with extensive fibrin exudation and 
necrosis, and neutrophil infiltration 
IH: Moderate numbers of cells in AL; cell free 
viral antigen in area with necrosis (IH, FHV: 
Negative) 
1.8 
 
DSH 4 weeks M Multifocal extensive fibrin exudation and abundant, often apoptotic AM/type 
II pneumocytes in AL, mild erythrocyte extravasation in AL. 
IH: Scattered desquamated cells in AL 
 
 637 
ESH, European shorthair; DSH, Domestic shorthair; BSH, British shorthair; MC, Maine Coon; F, female; M, male; N, neutered; NK, not 638 
known; AL, alveolar lumina; AM, alveolar macrophages; AS, anti-sense probe; AW, alveolar wall; FHV, feline herpesvirus type 1; ISH, 639 
RNA-in situ hybridisation; S, sense probe. 640 
a AM/type II pneumocytes, numerous CD18 positive AM and scattered individual SP-C positive type II pneumocytes. 641 
b Apoptosis/apoptotic: confirmed by IH (cleaved caspase-3 positive). 642 
  
643 
 Table 2 644 
Relevant gross and histological findings for group 2: Cats with upper respiratory disease (URD) and pneumonia, 645 
involvement of feline calicivirus (FCV) confirmed by immunohistochemistry (IH) for FCV antigen. 646 
 647 
Case  Breed Age Sex Lung histopathology  Demonstration of FCV 
2.1 DSH 12 weeks M Multifocal moderate fibrin exudation and very abundant AM/type II 
pneumocytes in AL; bronchioles with similar content 
IH: Low number of cells in AL and in 
bronchiolar lumina 
2.2 
 
DSH 4 years F Multifocal mild fibrin exudation and moderate numbers of AM/type II 
pneumocytes in AL 
IH: Scattered cells in AL 
(IH, FHV: negative) 
2.3 
 
DSH 8 weeks F Multifocal extensive fibrin exudation and moderate to large numbers 
of AM/type II pneumocytes in AL 
IH: Several cells in AL 
ISH (S, AS): Several cells in AL 
(IH, FHV: Negative) 
2.4 Oriental 12 weeks F Mutifocal low to moderate numbers of AM/type II pneumocytes in 
AL 
IH: Several cells in AL 
2.5 DSH 3.5 years MN Multifocal moderate fibrin exudation and abundant, often apoptotic 
AM/type II pneumocytes in AL; mild focal type II pneumocyte 
hyperplasia; moderate interstitial macrophage infiltration 
IH: Moderate to high number of cells in AW 
(type II pneumocytes). 
(IH, FHV: Negative) 
2.6 
 
DSH 11 weeks F Multifocal moderate fibrin exudation and moderate numbers of 
occasionally apoptotic AM/type II pneumocytes in AL; moderate 
amount of lymphocytes and plasma cells in interstitium 
IH: Moderate number of cells in AL 
(IH, FHV: Negative) 
 648 
DSH, Domestic Shorthair; F, female; M, male; N, neutered; AM, alveolar macrophages; AW, alveolar wall; AL, alveolar lumina; ISH, RNA-649 
in situ hybridisation; S, sense probe; AS, anti-sense probe; FHV, Feline herpesvirus type 1.  650 
 Table 3 651 
Relevant gross and histological findings for group 3: Cats without upper respiratory disease (URD) and 652 
histological findings consistent with feline calicivirus (FCV) pneumonia, involvement of FCV confirmed by 653 
immunohistochemistry (IH) for FCV antigen. 654 
 655 
Case Breed Age Sex Primary disease Lung histopathology Demonstration of FCV 
3.1 
 
DSH 8 weeks M Feline parvovirus enteritis Multifocal fibrin exudation and abundant, partly 
apoptotic AM/type II pneumocytes; mild to moderate 
multifocal type II pneumocyte hyperplasia; moderate 
interstitial macrophage infiltration 
IH: Moderate number of cells in AL 
ISH (S, AS): Several cells in AL 
3.2 
 
BSH 1 year MN Feline parvovirus enteritis Multifocally, low numbers of partly apoptotic 
AM/type II pneumocytes in AL  
IH: Scattered cells in AW (type II 
pneumocytes?) or in AL 
 656 
DSH, Domestic shorthair; BSH, British shorthair; M, male; N, neutered; AM, alveolar macrophages; AW, alveolar wall; AL, alveolar 657 
lumina; ISH, RNA-in situ hybridisation; S, sense probe; AS, anti-sense probe.
 
 658 
 Table 4 659 
Relevant gross and histological findings for group 4: Cats with virulent systemic feline calicivirus (FCV) and 660 
demonstration of FCV antigen in the lungs by immunohistochemistry (IH) 661 
 662 
Case  Breed Age Sex Lung histopathology  Demonstration of FCV 
4.1 a 
 
DSH 3 years FN Multifocal desquamation of low numbers of AM/type II 
pneumocytes 
Isolation and PCR (oropharyngeal swab); PCR 
IH: Several cells in AL 
4.2 b 
 
DSH 10 years MN Multifocally, low numbers of AM/type II pneumocytes in AL FCV (oropharyngeal swab, tissues); PCR 
IH: Several cells in AL 
4.3 
 
DSH 6 weeks NK Multifocal marked fibrin exudation and moderate numbers of 
partly apoptotic AM/type II pneumocytes in AL; focal 
extensive apoptosis and loss of bronchiolar epithelial cells  
IH: Moderate number of intact and apoptotic cells and 
cell free in AL 
ISH (S, AS): Moderate number of (apoptotic) cells in 
AL and focally numerous (apoptotic) bronchiolar 
epithelial cells 
4.4 c 
 
DSH Adult M Multifocally, low numbers of AM/type II pneumocytes in AL Isolation (spleen); PCR; IH: A few cells in AL 
 663 
DSH, Domestic shorthair; F, female; M, male; N, neutered; NK, not known; AM, alveolar macrophages; AL, alveolar lumina; ISH, RNA-in 664 
situ hybridisation; S, sense probe; AS, anti-sense probe 665 
a Coyne et al. (2006). 666 
b Battilani et al. (2013). 667 
c Velasco et al. (2013).  668 
 Table 5 669 
Antibodies, detection method and antigen retrieval for immunohistochemistry. 670 
 671 
Antibody Source Antigen retrieval Detection method 
Rabbit anti-FCV capsid University of Liverpool (Coyne et al., 2006) CB pH 6.0, 96 °C PAP 
Mouse anti-FCV (clone FCV2-16) Custom Monoclonals International  CB pH 6.0, 96 °C PAP 
Mouse anti-FHV (clone FHV5) Custom Monoclonals International None PAP 
Mouse anti-SP-C (clone FL-197) Santa Cruz Biotechnology  None PAP 
Rabbit anti-cleaved caspase 3 Cell Signaling  CB pH 6.0, 96 °C PAP 
Mouse anti-feline CD18 (clone FE3.9F2) Leukocyte Antigen Biology Laboratory (University of 
California)  
Bacterial protease HP (Envision; Dako) 
Mouse anti-human MMP-9 (clone IIA5) NeoMarkers  CB pH 6.0, 96 °C PAP 
 672 
FCV, feline calicivirus; FHV, feline herpesvirus; SC, surfactant protein; MMP, matrix metalloproteinase; CB, citrate buffer; PAP, peroxidase 673 
anti-peroxidase method; HP, horseradish peroxidase method.674 
  675 
 Figure legends 676 
 677 
Fig.1. Histological features of feline calicivirus (FCV)-associated lung lesions. (A) Cat with 678 
upper respiratory disease (URD) and isolation of FCV from the lung (cat 1.2). Variable 679 
numbers of desquamated alveolar macrophages (arrows) and scattered neutrophils and small 680 
amounts of fibrin (arrowhead) are present in alveolar lumina. Bar = 20 µm. (B) Cat with URD 681 
and immunohistochemical confirmation of FCV infection (cat 2.5). Alveoli contain variable 682 
numbers of desquamated alveolar macrophages (arrows) and a few extravasated erythrocytes. 683 
Type II pneumocytes (arrowheads) often appear activated. Bar = 20 µm. (C) Cat without 684 
URD, but with immunohistochemical confirmation of FCV infection (cat 3.1). Apart from the 685 
presence of fibrin and desquamated cells in alveolar lumina (arrowhead), moderate type II 686 
pneumocyte hyperplasia (arrows) is seen in several alveoli. Bar = 20µm. (D) Cat with virulent 687 
systemic FCV (cat 4.3). Alveoli contain abundant fibrin and several apoptotic alveolar 688 
macrophages (arrowheads). The bronchiole exhibits focal apoptotic loss of respiratory 689 
epithelial cells (arrow). Bar = 20 µm. Haematoxylin and eosin staining. 690 
 691 
Fig. 2. Immunohistochemical characterisation of feline calicivirus (FCV)-associated lung 692 
lesions. (A) Cat with upper respiratory disease (URD) and isolation of FCV from the lung (cat 693 
1.2). Expression of CD18 is seen in the vast majority of desquamated cells, which can be 694 
identified as alveolar macrophages. Horseradish peroxidase method. Bar = 20µm. (B, C) Cat 695 
with URD and immunohistochemical confirmation of FCV infection (cat 2.5). (B) Staining 696 
for surfactant protein-C identifies type II pneumocytes (arrowheads), either attached to the 697 
alveolar wall or, occasionally, desquamated. Peroxidase anti-peroxidase method. Bar = 20 698 
µm. (C) MMP-9 expression is seen in both desquamated alveolar macrophages (arrows) and 699 
activated type II pneumocytes (arrowhead). Peroxidase anti-peroxidase method. Bar = 10 µm. 700 
 (D) Cat without URD and immunohistochemical confirmation of FCV infection (cat 3.1). 701 
Staining for cleaved caspase-3 confirms that numerous desquamated cells in alveolar lumina 702 
undergo apoptosis (arrows). Peroxidase anti-peroxidase method. Bar = 20 µm. Papanicolaou’s 703 
haematoxylin counterstain. 704 
 705 
Fig.3. Expression of feline calicivirus (FCV) antigen in FCV-associated lung lesions. (A) Cat 706 
with upper respiratory disease (URD) and isolation of FCV from the lung (cat 1.2). Numerous 707 
desquamated alveolar macrophages (arrows) and scattered type II pneumocytes in the alveolar 708 
wall express viral antigen. Bar = 20 µm. (B) Cat with URD and immunohistochemical 709 
confirmation of FCV infection (cat 2.5). Apart from desquamated alveolar macrophages 710 
(arrows), a few type II pneumocytes attached to the alveolar wall (arrowheads) express viral 711 
antigen. Bar = 10 µm. (C) Cat without URD and immunohistochemical confirmation of FCV 712 
infection (cat 3.1). Numerous, often apoptotic cells in alveolar lumina (arrows) express viral 713 
antigen. Bar = 20 µm. Inset: FCV antigen expression in an activated type II pneumocyte. Bar 714 
= 10 µm. (D) Cat with VS-FCV (cat 4.3). Alveoli contain numerous cells, often apoptotic 715 
(arrows), that express viral antigen. A bronchiole exhibits focal loss and apoptosis of 716 
respiratory epithelial cells that exhibit strong viral antigen expression (arrow heads). 717 
Numerous FCV antigen positive degenerate cells are also found in the bronchiolar lumen 718 
(BL). Bar = 20 µm. Peroxidase anti-peroxidase method. Papanicolaou’s haematoxylin 719 
counterstain. 720 
 721 
Fig. 4. Demonstration of feline calicivirus (FCV) genome and replication in FCV-associated 722 
lung lesions. (A) Cat with upper respiratory disease (URD) and isolation of FCV from the 723 
lung (cat 1.2). Several, partly apoptotic desquamated cells in the alveolar lumen show a 724 
positive signal (arrows) for positive strand viral RNA (top); a few also express negative 725 
 strand, replicative intermediate stage viral RNA (bottom). Bars = 20 µm. (B, C) Cat with 726 
URD and immunohistochemical confirmation of FCV infection (cat 2.5). (B) Desquamated 727 
cells in the alveolar lumen show a positive signal (arrows) for positive strand viral RNA (top). 728 
Activated type II pneumocytes exhibit a signal for negative strand, replicative intermediate 729 
stage viral RNA (bottom); V, vessel. Bars = 10 µm. (C) Focal areas with type II pneumocyte 730 
hyperplasia, with abundant signal for negative strand, replicative viral RNA (binding of sense 731 
probe) in type II cells (arrows). Bar = 20 µm. (D) Cat without URD or immunohistochemical 732 
confirmation of FCV infection (cat 3.1). Alveoli contain numerous cells, often apoptotic 733 
(arrows), that express negative strand, replicative viral RNA (arrows), detected by binding of 734 
the sense probe. A bronchiole exhibits focal loss and apoptosis of respiratory epithelial cells 735 
that exhibit strong signals for negative strand, replicative viral RNA (arrowheads). BL, 736 
bronchiolar lumen. Bar = 10 µm. RNA-in situ hybridisation; NBT/BCIP. Papanicolaou’s 737 
haematoxylin counterstain. 738 
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Revision Note 
 
We thank the editor and reviewers for their feedback on our manuscript and have carefully 
attended all their comments. 
 
Editor’s comment: 
We thank the editor for editing our manuscript. From the editor’s feedback, the main issue 
was the following:  
Your manuscript is currently 4134 words long. Can you please try to revise the 
word count down so that it is closer to the 3000 word limit for Original 
Articles in TVJ? 
Response: We have carefully gone through the manuscript again and have made some 
changes to shorten the text. However, the reviewers requested a few changes that then 
added further words to the manuscript. At present, it has a length (introduction to 
conclusions) of 3,902 words. We feel that further cuts would reduce the value of the 
manuscript but are happy to undertake another attempt if the editor wishes us to and is 
happy with a less thorough report and discussion.  
 
Reviewer #1:  
Thsi is a well conducted useful study which sheds new light on the role of FCV 
in the lungs of naturally infected cats.  
Response: We thank the reviewer for the positive comment. 
 
line 4 - can the authors's justify the use of the word "mediate" in the title 
Response: We agree with the reviewer that “mediate” might not be the best term to describe 
the role of alveolar macrophages in FCV-associated pneumonia and have therefore changed 
the title to “Alveolar macrophages are the main target cells in feline calicivirus-associated 
pneumonia” in the hope that the reviewer will agree with this title. 
 
Line 28 - there are some reports of FCV-like viruses in dogs (Martella V, 
Pratelli A, Gentile M, Buonavoglia D, Decaro N, Fiorente P, Buonavoglia C 
(2002). Analysis of the capsid protein gene of a feline-like calicivirus 
isoalted from a dog. Veterinary Microbiology, 85:315-322.)  
Response: In order to avoid any discussion about the host specificity, in particular in light of 
the publication mentioned by the reviewer, we have taken out the words “host specific”. 
 
Line 36 - VS in full Line 64 - don't need both "Caliciviridae" and "family" 
Response: The text has been shortened and this text passage been deleted. 
 
Line 68 - UDR 
Response: The text has been changed accordingly. 
 
Line 72 - C and E do not encode proteins, rather part of a protein 
Response: We are grateful to the reviewer for pointing this out and have changed the text 
accordingly. 
 
Line 188 - relatively conserved 
Response: The text has been changed accordingly. 
 
Line 735 - don't understand the "B, C" in the middle of this line. 
*Revision Note
Response: The “B, C.” refers to the subsequent text, meaning that Fig. 4B and C are from a 
“Cat with URD and immunohistological confirmation of FCV infection (case No. 2.5).” We 
believe that this is clear enough. 
  
Line 308 - this conclusion seems unproven. Yes you have lesions in a dead cat. 
But that does not mean the lesions were associated with the cause of death. 
Apologies if I am missing something. 
Response: The text has been changed to make the conclusion more understandable. For 
this purpose, we have again mentioned the severity of the pulmonary lesions (acute alveolar 
damage) which can alone be responsible for the animals’ death (lines 302 - 304 in the 
revised manuscript). 
  
Line 372 - don't need to repeat the (Langloss et al., 1978b),  
Response: The text has been changed accordingly. 
 
Line 374 - persistence. This got me thinking. I would be interested in the 
authors' thoughts on what they would see if they were able to carry out their 
analyses on a recovered cat. Perhaps some of the staining they see represents 
"normal" lung. Perhaps the authors should comment on the need to analyse such 
cases in subsequent studies, as an additional control. 
Response: This is an interesting point. The presence of hyperplastic tyoe II pneumocytes in 
some animals indicates recovery of the lungs from initial FCV induced alveolar epithelial cell 
damage. The fact that viral RNA was found in occasional hyperplastic type II cells indicates 
that the virus can persist in these cells. However, with further recovery, these cells would 
further differentiate, mainly into functional type I cells, to ensure effective gas exchange. It is 
unlikely that these fully differentiated cells would still carry FCV, and if they did, in amounts 
high enough to be detected by RNA-ISH. The more sensitive PCR would not help much, 
since it would not allow identification of infected cells. Therefore, this question could only be 
addressed in a large experimental study, which would be extremely difficult to realise, at 
least in Europe. 
   
Line 382/3 - don't need both family and Coronviridae 
Response: The word “family” has been deleted. 
 
Line 387 - have you formally confirmed? You have shown apoptosis. You have 
shown FCV infection. But you can't prove a link between the two. The figure 2d 
legend has it about right. Or perhaps I have missed the logic. I think you can 
say you have provided further evidence, this time in vivo, for ….. 
Response: The staining of consecutive sections demonstrates FCV and the apoptosis 
marker in the same lesion and thereby group of cells, which we consider as sufficient to use 
the term “confirm”. However, since we have not performed double staining, we of course did 
not show both features in the same cell. Therefore, the statement has been toned down (line 
376 in the revised manuscript). 
 
Line 393-398 - Possibly delete this last paragraph. 
Response: We have decided to keep the text.  
 
Line 405 - again, possibly delete the sentence relating to immunosuppressed 
cats. 
Response: The sentence has been deleted. 
  
Figure 2 legend may be made easier to follow by starting each section with the 
name of the antigen target. This reviewer found it hard to decipher.  
Response: The text has been amended to provide information on the antigens that are 
detected at the beginning of each sentence on the relevant photo. 
 
 
Reviewer #2:  
In this study the involvement of FCV infection in pulmonary lesions in cats 
with natural respiratory disease was determined. So far mainly data  from 
experimental infections are known which may not represent the type and extent 
of lesions found in naturally infected cats. Therefore, this study adds to our 
knowledge of the pathogenesis of FCV infection in domestic cats.  
The study was done with a selected number of cats in which pulmonary 
involvement was already evidenced by virus isolation or virus antigen 
detection by immunohistochemical staining. Several genetic and immunological  
tools were used to identify the type of cells and the presence of viral 
antigen and/or viral replication. These tools and techniques provide 
sufficient information to draw the conclusions about the type and extent of 
lung lesions. There are some ambiguities regarding materials and methods that 
need to be addressed. Also some of the results need to be clarified. 
 
Comments 
- Four different groups of cats were included in the study. The second group 
consists of cats that had URD and pneumonia in which FCV involvement was 
evidenced only by immunohistology. From the M&M paragraph it is not clear if 
virus isolation was not performed or was  performed but unsuccessful. In the 
results section authors state that FCV involvement was confirmed by 
immunohistology alone, which does not exclude that virus isolation was 
attempted. Only when reading the discussion it becomes clear that virological 
examination had not been undertaken. 
Response: We agree with the reviewer; the text in M&M was ambiguous. We have 
amended it to clarify that virus culture was only undertaken in animals of group 1 (lines 130 
and 131 in the revised manuscript). 
  
- Besides staining for FCV antigen some samples were stained for FHV  as well. 
It is not clear why only a selected number of cases were stained for FHV and 
which criteria were used to decide whether staining was performed or not.  
This information should be included. 
Response: The immunohistology for FHV was done to exclude that FHV played a role in the 
lung lesions. It was therefore mainly done in group 2, where virus culture was not performed, 
which itself ruled out FHV infection of the lung when negative (Group 1). We have provided 
information on this in the M&M section (lines 151-153 in the revised manuscript). 
 
-  In cats from group 1, one case (No. 1.5) was shown to exhibit co-infection 
with FHV and FCV. However FHV staining was only performed in 3 out of 8 cats. 
The relevance of this finding should be discussed knowing that not all cats 
were screened for the presence of FHV (see also previous comment). Also the 
conclusion that co-infection was found in a few cases (discussion, last 
paragraph) seems of little value if not all samples were tested. 
Response: As mentioned above, immunohistology for FHV was performed in the lungs to 
confirm that only FCV was involved. We consider this as relevant in the cats with FCV 
pneumonia in which virus culture had not been performed (group 2). We have tried to make 
this clearer in the text (results sections: lines 254/255). 
 
- Staining for FCoV was only performed in 2 cases (based on the information in 
Table 1). The reason for  performing this staining only in these 2 cases  is 
not discussed.  This cannot be concluded based on the histological information 
given in table 1. 
Response: We did undertake FCoV immunohistologie in just a few cases, as a diagnostic 
panel that had been decided upon at the time of necropsy. However, we agree with the 
reviewer that this does not add anything to the manuscript and have therefore deleted all 
mentioning of the FCoV immunohistology, since FIP was not a differential diagnosis in any of 
these cases. 
  
-  Negative controls for the in situ hybridization are important to proof the 
specificity of the reactions. Information on the negative controls used in the 
in situ hybridization is lacking. These should be included and discussed. 
Response: Information on the negative controls for ISH is now provided (lines 209/201 in 
the revised manuscript). 
  
- In the results section authors refer to the occasional extravasation of 
erythrocytes into the alveolar lumen (fig 1B,C). This is not mentioned in the 
legend of the figure and also not indicated within the figure. 
Response: Erythrocyte extravasation into the alveolar lumen is obvious in particular in Fig. 
1B. A reference to this has now been included into the figure legend and the text been 
changed accordingly. 
 
A few typos . 
Introduction Line 68: self limiting UDR; should be: URD  
Response: The text has been changed accordingly. 
 
Introduction line 100 "into the aleolar lumen": change to: alveolar 
Response: The text has been changed accordingly. 
 
Discussion, line 383; Coronviridae: change to Coronaviridae 
Response: The text has been changed accordingly. 
 
 
We hope that the revised manuscript will now be acceptable for publication in The Veterinary 
Journal. 
Sincerely, 
Anja Kipar  
